BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36358865)

  • 1. Prostate Cancer Stem Cells: The Role of CD133.
    Yang J; Aljitawi O; Van Veldhuizen P
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential interaction of platelets with prostate cancer cells with stem cell markers.
    Rudzinski JK; Govindasamy NP; Asgari A; Saito MS; Lewis JD; Jurasz P
    Thromb Res; 2021 Oct; 206():42-51. PubMed ID: 34403851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonic hedgehog signaling is associated with resistance to zoledronic acid in CD133high/CD44high prostate cancer stem cells.
    Acikgoz E; Mukhtarova G; Alpay A; Avci CB; Bagca BG; Oktem G
    Mol Biol Rep; 2021 Apr; 48(4):3567-3578. PubMed ID: 33948856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis.
    Mei W; Lin X; Kapoor A; Gu Y; Zhao K; Tang D
    Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30934773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase.
    Sarveswaran S; Varma NRS; Morisetty S; Ghosh J
    Oncotarget; 2019 Jan; 10(4):424-436. PubMed ID: 30728896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells in prostate cancer radioresistance.
    Tsao T; Beretov J; Ni J; Bai X; Bucci J; Graham P; Li Y
    Cancer Lett; 2019 Nov; 465():94-104. PubMed ID: 31493443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.
    Yun EJ; Lo UG; Hsieh JT
    Asian J Urol; 2016 Oct; 3(4):203-210. PubMed ID: 29264188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CD133 in hepatocellular carcinoma.
    Liu F; Qian Y
    Cancer Biol Ther; 2021 Apr; 22(4):291-300. PubMed ID: 33899676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
    Rentala S; Mangamoori LN
    J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
    Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Midkine Suppresses Prostate Cancer CD133
    Erdogan S; Doganlar ZB; Doganlar O; Turkekul K; Serttas R
    Am J Med Sci; 2017 Sep; 354(3):299-309. PubMed ID: 28918838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
    Aghajani M; Mokhtarzadeh A; Aghebati-Maleki L; Mansoori B; Mohammadi A; Safaei S; Asadzadeh Z; Hajiasgharzadeh K; Khaze Shahgoli V; Baradaran B
    Mol Biol Rep; 2020 May; 47(5):3691-3703. PubMed ID: 32246247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-197 Inhibitor Loaded AbCD133@MSNs@GNR Affects the Development of Prostate Cancer Through Targeting ITGAV.
    Ju G; Zhu Y; Du T; Cao W; Lin J; Li C; Xu D; Wang Z
    Front Cell Dev Biol; 2021; 9():646884. PubMed ID: 34195187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP.
    Sohn HM; Kim B; Park M; Ko YJ; Moon YH; Sun JM; Jeong BC; Kim YW; Lim W
    Oncol Lett; 2019 Aug; 18(2):1189-1198. PubMed ID: 31423179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
    Li K; Liu C; Zhou B; Bi L; Huang H; Lin T; Xu K
    Int J Mol Sci; 2013 Jun; 14(6):11981-93. PubMed ID: 23739676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells in progression of colorectal cancer.
    Zhou Y; Xia L; Wang H; Oyang L; Su M; Liu Q; Lin J; Tan S; Tian Y; Liao Q; Cao D
    Oncotarget; 2018 Sep; 9(70):33403-33415. PubMed ID: 30279970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between prostate cancer stem cells and bone microenvironment regulates prostate cancer bone metastasis and treatment resistance.
    Yao L; Zhang X
    J Cancer; 2022; 13(9):2757-2767. PubMed ID: 35812177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.